Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer

Julia DiGiovanni, Marko Popovic, Edward Chow*, David Cella, Jennifer L. Beaumont, Jasmine Nguyen, Dominic Chu, Anthony Adili, Natalie Pulenzas, Breanne Lechner, Henry Lam, Andrew Bottomley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This review aimed to compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQ-LC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQLC13 is clinically valid and useful. Conversely, the FACTL assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACTL was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.

Original languageEnglish (US)
Pages (from-to)103-113
Number of pages11
JournalJournal of Pain Management
Volume8
Issue number2
StatePublished - Sep 1 2015

Keywords

  • EORTC QLQ-C30
  • EORTC QLQ-LC13
  • FACT-G
  • FACT-L
  • Lung cancer
  • Oncology
  • Quality of Life

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Comparison of the EORTC QLQ-LC13 and the FACT-L for assessment of quality of life in patients with lung cancer'. Together they form a unique fingerprint.

Cite this